𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P.3.d.019 Reboxetine add-on to clozapine in treatment of negative symptoms of schizophrenia: a preliminary open-label study

✍ Scribed by Quattrone, D.; Bruno, A.; Micò, U.; Pandolfo, G.; Scimeca, G.; Muscatello, M.R.; Zoccali, R.


Book ID
123358210
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
59 KB
Volume
23
Category
Article
ISSN
0924-977X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Efficacy of selegiline add on therapy to
✍ Afshar Amiri; Ahmad-Ali Noorbala; Ali-Akbar Nejatisafa; Abolfazl Ghoreishi; Moha 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

## Abstract ## Objective It has been reported that selegiline, a Selective Monoamine Oxidase Inhibitor B (MAOI‐B), at low doses would be helpful for treating negative symptoms in schizophrenia. Nevertheless, the results are contradictory so far. This study was designed to investigate the effect of